|
Dr. Gleba has over 30 years of research and management experience in plant genetics and biotechnology. (M. Sc., Kiev University, 1971; Ph.D., Institute of Botany, Academy of Sciences of Ukraine; D.Sc., Leningrad University, 1980). He founded the Institute of Cell Biology and Genetic Engineering, Kiev, Ukraine, in 1989 and is still serving as its Director. Dr. Gleba's pioneering research in plant cell biology, genetics and physiology were published in more than 200 research papers, books and over 30 patents, and has earned the respect of the international scientific community as is evidenced by his election to the World Academy of Arts and Science, the European Academy (Academia Europaea), the National German Academy Leopoldina, the Ukrainian Academy of Sciences, the Lithuanian Academy of Science and the Bavarian Academy of Sciences, numerous international and national awards and prizes, including Koerber Prize, A. von Humboldt Prize, USSR State Prize, State Prize of Ukraine, etc. Dr. Gleba joined American Cyanamid Company, Princeton, NJ in 1992, where he developed research efforts in plant biotechnology and genomics and crop engineering, first as a group leader/manager, and, since 1997, as a Director of the Crop Engineering Department. Dr. Gleba left American Cyanamid in February, 1999, to co-found ICON GENETICS, and was serving as its first CEO, and after acquisition of Icon by Bayer, as Icon's Managing Director. |
Yuri Gleba, Ph.D. |
|
Dr. Gleba has over 30 years of research and management experience in plant genetics and biotechnology. (M. Sc., Kiev University, 1971; Ph.D., Institute of Botany, Academy of Sciences of Ukraine; D.Sc., Leningrad University, 1980). He founded the Institute of Cell Biology and Genetic Engineering, Kiev, Ukraine, in 1989 and is still serving as its Director. Dr. Gleba's pioneering research in plant cell biology, genetics and physiology were published in more than 200 research papers, books and over 30 patents, and has earned the respect of the international scientific community as is evidenced by his election to the World Academy of Arts and Science, the European Academy (Academia Europaea), the National German Academy Leopoldina, the Ukrainian Academy of Sciences, the Lithuanian Academy of Science and the Bavarian Academy of Sciences, numerous international and national awards and prizes, including Koerber Prize, A. von Humboldt Prize, USSR State Prize, State Prize of Ukraine, etc. Dr. Gleba joined American Cyanamid Company, Princeton, NJ in 1992, where he developed research efforts in plant biotechnology and genomics and crop engineering, first as a group leader/manager, and, since 1997, as a Director of the Crop Engineering Department. Dr. Gleba left American Cyanamid in February, 1999, to co-found ICON GENETICS, and was serving as its first CEO, and after acquisition of Icon by Bayer, as Icon's Managing Director.
send email to Yuri Gleba
